Table 1.
Characteristics of 128 patients examined with restaging [18F]PSMA-1007 PET/CT.
| Characteristics (n) | Parameters |
|---|---|
| Number of [18F]PSMA-1007 PET/CT patients | 128 |
| Age (y) | |
| - Median | 69 |
| - Range | 51–96 |
| Mean ± SD | 69.3 ± 8.8 |
| Gleason Score | |
| - ≤6 (low risk + grade group 1) | 9 |
| - 7 (intermediate risk + grade group 2 + 3) | 63 |
| - 8 (high risk + grade group 4) | 20 |
| - >8 (high risk + grade group 5) | 36 |
| PSA (ng/mL) | |
| - Median | 1.6 |
| - Range | 0.1–167.1 |
| - Mean ± SD | 7.0 ± 18.6 |
| Pretreatment of primary tumor | |
| - Surgery (radical prostatectomy) | 84 |
| - Radiotherapy | 44 |
| Further treatment | |
| - Androgen deprivation therapy | 74 |
| Positivity rate | |
| - PET/CT positive patients/total | 112/128 |
Abbreviations: PSA, prostate-specific antigen; SD, standard deviation; n, number of patients; y, year.